🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Arvinas, Inc.

Arvinas, Inc. logo
Market Cap: High
Employees: Medium

Bavdegalutamide, ARV-471, ARV-766

Arvinas, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company is based in New Haven, Connecticut and collaborates with organizations like Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG.

Tags: PROTAC, biopharmaceutical, cancer therapy, clinical-stage, protein degrader

Symbol: ARVN

Recent Price: $19.00

Industry: Biotechnology

CEO: Dr. John G. Houston Ph.D.

Sector: Healthcare

Employees: 445

Address: 5 Science Park, New Haven, CT 06511

Phone: 203 535 1456

Leadership

  • John G. Houston, Ph.D., Chairperson, Chief Executive Officer, and President
  • Noah Berkowitz, M.D., Ph.D., Chief Medical Officer
  • Angela M. Cacace, Ph.D., Chief Scientific Officer
  • Jared Freedberg, J.D., General Counsel and Corporate Secretary
  • Paul McInulty, Senior Vice President, Regulatory Affairs
  • John Northcott, Chief Commercial Officer
  • Kelly Page, Senior Vice President, Global Head of Oncology Strategy and Program Leadership
  • Andrew Saik, Chief Financial Officer
  • Lisa Sinclair, Senior Vice President, Corporate Operations
  • Ian Taylor, Ph.D., President, R&D
  • Randy Teel, Ph.D., Chief Business Officer
  • Steve Weiss, Senior Vice President, Chief Human Resources Officer

Last updated: 2024-12-31